Trans‐complementing adenoviral vectors for oncolytic therapy of malignant melanoma

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Gene Medicine

• Publication date

  2004-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/jgm.551PMID 15170736
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Recombinant adenovirus encoding H-ras ribozyme induces apoptosis in laryngeal cancer cells through caspase- and mitochondria-dependent pathways.

  2002cited by this paper
• Phase I trial of intraperitoneal injection of the E1B-55-kd-gene-deleted adenovirus ONYX-015 (dl1520) given on days 1 through 5 every 3 weeks in patients with recurrent/refractory epithelial ovarian cancer.

  2002cited by this paper
• Efficacy and toxicity of replication-competent adenovirus-mediated double suicide gene therapy in combination with radiation therapy in an orthotopic mouse prostate cancer model.

  2002cited by this paper
• Lethal Toxicity, Severe Endothelial Injury, and a Threshold Effect with High Doses of an Adenoviral Vector in Baboons

  2002cited by this paper
• Enzyme-activated Prodrug Therapy Enhances Tumor-specific Replication of Adenovirus Vectors.

  2002cited by this paper
• Impact of preimmunization on adenoviral vector expression and toxicity in a subcutaneous mouse cancer model.

  2002cited by this paper
• Adenoviral vectors: Systemic delivery and tumor targeting

  2002cited by this paper
• Integrin alpha(v) and coxsackie adenovirus receptor expression in clinical bladder cancer.

  2002cited by this paper
• Subcutaneous Administration of a Replication-Competent Adenovirus Expressing HSV-tk to Cotton Rats: Dissemination, Persistence, Shedding, and Pathogenicity

  2002cited by this paper
• Evaluation of E1B gene-attenuated replicating adenoviruses for cancer gene therapy

  2002cited by this paper
• Phase 1 clinical trial of irradiated autologous melanoma cells adenovirally transduced with human GM-CSF gene

  2001cited by this paper
• Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancer.

  2001cited by this paper
• Adenovirus‐mediated CD40 ligand gene therapy in a rat model of orthotopic hepatocellular carcinoma

  2001cited by this paper
• A death in the laboratory: the politics of the Gelsinger aftermath.

  2001cited by this paper
• Re-engineering adenovirus regulatory pathways to enhance oncolytic specificity and efficacy

  2001cited by this paper
• Evaluation of the biodistribution, persistence, toxicity, and potential of germ-line transmission of a replication-competent human adenovirus following intraprostatic administration in the mouse.

  2000cited by this paper
• An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy

  2000cited by this paper
• The role of the E1B 55 kDa gene product in oncolytic adenoviral vectors expressing herpes simplex virus-tk: assessment of antitumor efficacy and toxicity.

  2000cited by this paper
• Trans-complementation of vector replication versus Coxsackie-adenovirus-receptor overexpression to improve transgene expression in poorly permissive cancer cells

  2000cited by this paper
• Differential gene expression in p53-mediated apoptosis-resistant vs. apoptosis-sensitive tumor cell lines.

  2000cited by this paper
• Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer.

  2000cited by this paper
• Blood clearance rates of adenovirus type 5 in mice.

  2000cited by this paper
• Gene therapy: trials and tribulations

  2000cited by this paper
• Loss of adenoviral receptor expression in human bladder cancer cells: a potential impact on the efficacy of gene therapy.

  1999cited by this paper
• Basolateral Localization of Fiber Receptors Limits Adenovirus Infection from the Apical Surface of Airway Epithelia*

  1999cited by this paper
• Induction of apoptosis by adenovirus E4orf4 protein is specific to transformed cells and requires an interaction with protein phosphatase 2A.

  1999cited by this paper
• Complementary adenoviral vectors for oncolysis

  1999cited by this paper
• Enzyme prodrug gene therapy: synergistic use of the herpes simplex virus-cellular thymidine kinase/ganciclovir system and thymidylate synthase inhibitors for the treatment of colon cancer.

  1999cited by this paper
• Wild-type p53 induction mediated by replication-deficient adenoviral vectors.

  1999cited by this paper
• Intravenous administration of ONYX-015, a selectively replicating adenovirus, induces antitumoral efficacy.

  1999cited by this paper
• Therapy of colon cancer with oncolytic adenovirus is enhanced by the addition of herpes simplex virus-thymidine kinase.

  1999cited by this paper
• Efficacy of adenovirus-mediated CD/5-FC and HSV-1 thymidine kinase/ganciclovir suicide gene therapies concomitant with p53 gene therapy.

  1999cited by this paper
• Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma.

  1998cited by this paper
• Adenovirus-Mediated Herpes Simplex Virus Thymidine Kinase/Ganciclovir Gene Therapy in Patients with Localized Malignancy: Results of a Phase I Clinical Trial in Malignant Mesothelioma

  1998cited by this paper
• Adenovirus Type 5 E4 Open Reading Frame 4 Protein Induces Apoptosis in Transformed Cells

  1998cited by this paper
• Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2.

  1998cited by this paper
• Severe hepatic dysfunction after adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene and ganciclovir administration

  1998cited by this paper
• Efficient directional cloning of recombinant adenovirus vectors using DNA-protein complex.

  1998cited by this paper
• ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents

  1997cited by this paper
• Viral vector-mediated transduction of a modified platelet factor 4 cDNA inhibits angiogenesis and tumor growth

  1997cited by this paper
• Gene therapy - promises, problems and prospects

  1997cited by this paper
• Characterization of the antitumor immune response generated by treatment of murine tumors with recombinant adenoviruses expressing HSVtk, IL-2, IL-6 or B7-1

  1997cited by this paper
• Conditionally replicative adenoviruses for cancer therapy.

  1997cited by this paper
• Interleukin 12 and B7-1 costimulatory molecule expressed by an adenovirus vector act synergistically to facilitate tumor regression.

  1997cited by this paper
• Liver-associated toxicity of the HSV-tk/GCV approach and adenoviral vectors.

  1997cited by this paper
• Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells

  1997cited by this paper
• Adenovirus E4 open reading frame 4 protein autoregulates E4 transcription by inhibiting E1A transactivation of the E4 promoter

  1996cited by this paper
• In vitro evaluation of a p53‐expressing adenovirus as an anti‐cancer drug

  1996cited by this paper
• Adenovirus type 5 early region 4 is responsible for E1A-induced p53-independent apoptosis

  1996cited by this paper
• E1A RNA transcripts amplify adenovirus-mediated tumor reduction.

  1996cited by this paper
• Kringle Domains of Human Angiostatin

  1996cited by this paper
• Replicating viruses as selective cancer therapeutics.

  1996cited by this paper
• Adenovirus‐mediated gene transfer of wild‐type p53 results in melanoma cell apoptosis in vitro and in vivo

  1995cited by this paper
• Lack of evidence of phenotypic complementation of E1A/E1B-deleted adenovirus type 5 upon superinfection by wild-type virus in the cotton rat

  1995cited by this paper
• In situ delivery of suicide genes for cancer treatment.

  1994cited by this paper
• Short and long term dissemination of deletion mutants of adenovirus in permissive (cotton rat) and non-permissive (mouse) species.

  1994cited by this paper
• Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma.

  1994cited by this paper
• In vivo antitumor activity of 5-fluorocytosine on human colorectal carcinoma cells genetically modified to express cytosine deaminase.

  1993cited by this paper
• Adenovirus early region 4 and viral DNA synthesis.

  1993cited by this paper
• Adenovirus E4orf4 protein binds to protein phosphatase 2A, and the complex down regulates E1A-enhanced junB transcription

  1993cited by this paper
• Coupling of adenovirus to transferrin-polylysine/DNA complexes greatly enhances receptor-mediated gene delivery and expression of transfected genes.

  1992cited by this paper
• Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: a negative selection system.

  1992cited by this paper
• Adenovirus E4orf4 protein reduces phosphorylation of c-Fos and E1A proteins while simultaneously reducing the level of AP-1

  1992cited by this paper
• High-Efficiency Gene Transfer Mediated by Adenovirus Coupled to DNA–Polylysine Complexes

  1992cited by this paper
• Complementation of adenovirus E4 mutants by transient expression of E4 cDNA and deletion plasmids.

  1989cited by this paper
• Murine mammary FM3A carcinoma cells transformed with the herpes simplex virus type 1 thymidine kinase gene are highly sensitive to the growth‐inhibitory properties of (E)‐5‐(2‐bromovinyl)‐2'‐deoxyuridine and related compounds

  1985cited by this paper
• Infection of mouse liver by human adenovirus type 5.

  1978cited by this paper
• Characteristics of a human cell line transformed by DNA from human adenovirus type 5.

  1977cited by this paper
• Trimmed Spearman-Karber Method for Estimating Median Lethal Concentrations in Toxicity Bioassays

  1977cited by this paper
• Adenovirus recombination: physical mapping of crossover events.

  1975cited by this paper
• Studies on the use of viruses in the treatment of carcinoma of the cervix

  1956cited by this paper
• Studies on the use of viruses in the treatment of carcinoma of the cervix.

  1956cited by this paper

• Microbial cancer therapeutics: A promising approach.

  2021cites this paper
• Cancer Treatment Goes Viral: Using Viral Proteins to Induce Tumour-Specific Cell Death

  2019cites this paper
• Mechanisms of Cancer Cell Killing by the Adenovirus E4orf4 Protein

  2015cites this paper
• Viral genes as oncolytic agents for cancer therapy

  2014cites this paper
• Induction of cancer-specific cell death by the adenovirus E4orf4 protein.

  2014cites this paper
• Analysis of adenovirus trans-complementation-mediated gene expression controlled by melanoma-specific TETP promoter in vitro

  2010cites this paper
• hTERT‐promoter‐dependent oncolytic adenovirus enhances the transduction and therapeutic efficacy of replication‐defective adenovirus vectors in pancreatic cancer cells

  2010cites this paper
• Environmental risk assessment of replication competent viral vectors in gene therapy trials

  2008cites this paper
• Evaluation of twenty-one human adenovirus types and one infectivity-enhanced adenovirus for the treatment of malignant melanoma.

  2008cites this paper
• Therapeutic immune response induced by intratumoral expression of the fusogenic membrane protein of vesicular stomatitis virus and cytokines encoded by adenoviral vectors.

  2007cites this paper
• Intratumoral expression of respiratory syncytial virus fusion protein in combination with cytokines encoded by adenoviral vectors as in situ tumor vaccine for colorectal cancer

  2007cites this paper
• In situ tumor vaccination with adenovirus vectors encoding measles virus fusogenic membrane proteins and cytokines.

  2007cites this paper
• Viral elements sense tumorigenic processes: approaching selective cancer therapy.

  2007cites this paper
• Comparison of herpes simplex virus- and conditionally replicative adenovirus-based vectors for glioblastoma treatment

  2007cites this paper
• Adenoviral p53 gene transfer and gemcitabine in three patients with liver metastases due to advanced pancreatic carcinoma.

  2007cites this paper
• Mechanistic analysis and comparison of viral fusogenic membrane proteins for their synergistic effects on chemotherapy

  2007cites this paper
• Role of p53 up-regulated modulator of apoptosis and phosphorylated Akt in melanoma cell growth, apoptosis, and patient survival.

  2006cites this paper
• In vivo imaging of adenovirus transduction and enhanced therapeutic efficacy of combination therapy with conditionally replicating adenovirus and adenovirus-p27.

  2006cites this paper
• Viral vectors for gene-directed enzyme prodrug therapy.

  2006cites this paper
• mda-7/IL-24: multifunctional cancer-specific apoptosis-inducing cytokine.

  2006cites this paper
• Synergy between expression of fusogenic membrane proteins, chemotherapy and facultative virotherapy in colorectal cancer

  2006cites this paper
• Evaluation of Twenty Human Adenoviral Types and One Infectivity-Enhanced Adenovirus for the Therapy of Soft Tissue Sarcoma

  2006cites this paper
• University of Groningen Exogenous and endogenous gene regulation for specific and efficient cancer gene therapy

  2006cites this paper
• Exogenous and endogenous gene regulation for specific and efficient cancer gene therapy

  2006cites this paper
• Enhanced killing of pancreatic cancer cells by expression of fusogenic membrane glycoproteins in combination with chemotherapy

  2006cites this paper